QoL · preventing mental disorders
2 findings from 1 review
Adverse events at study endpoint · preventing mental disorders
2 findings from 1 review
Psychological functioning and impairment at study endpoint (higher score = higher disability) · preventing mental disorders
2 findings from 1 review
Depressive symptoms · preventing mental disorders
2 findings from 1 review
Anxiety · preventing mental disorders
2 findings from 1 review
Distress/PTSD symptoms at study endpoint (higher score = higher severity) · preventing mental disorders
2 findings from 1 review
Diagnosis of mental disorders at study endpoint · preventing mental disorders
2 findings from 1 review
QoL · preventing mental disorders
2 findings from 1 review
Taking adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in taking adherence compared with standard care (low certainty).
1 finding from 1 review
Dosing adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence may leads to higher dosing adherence compared with standard care (low certainty).
1 finding from 1 review
Timing adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in timing adherence compared with standard care (low certainty).
1 finding from 1 review
Drug holidays · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in drug holidays compared with standard care (low certainty).
1 finding from 1 review
Adherence · solid organ transplant recipients
It is very uncertain whether interventions for increasing immunosuppressant medication adherence changes self‐reported adherence (proportion) compared with standard care (very low certainty).
2 findings from 1 review
Proportion of immunosuppressant trough concentration levels at target · solid organ transplant recipients
It is very uncertain whether interventions for increasing immunosuppressant medication adherence changes proportion of immunosuppressant trough concentration levels at target compared with standard care (very low certainty).
1 finding from 1 review
Ibuprofen vs placebo
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: mean loss
Interventions (ibuprofen, tolfenamic acid, aspirin, tranexamic acid) showed no clear difference in menstrual blood loss (alkaline hematin method) compared with placebo or active comparators (paracetamol, tranexamic acid); GRADE not reported.
2 findings from 1 review
MD 14.11
Studies not reported
GRADE not reported
MD 0.3
Studies not reported
GRADE not reported
Duration of bleeding (menstrual diary)
Interventions (ibuprofen, tolfenamic acid, aspirin, tranexamic acid) showed no clear difference in duration of bleeding (menstrual diary) compared with placebo or active comparators (paracetamol, tranexamic acid); GRADE not reported.
1 finding from 1 review
MD 0.2
Studies not reported
GRADE not reported
Side effects: eye and mouth swelling, stomach cramps, fatigue, irritability (diary record)
1 finding from 1 review
no estimate extracted
2 participants
GRADE not reported
Menstrual blood loss Menstruation "more abundant than normal" (questionnaire)
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Side effects: dyspepsia, diarrhoea, headache, fatigue (questionnaire)
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported